» Articles » PMID: 27992392

Animal Models for Central Poststroke Pain: a Critical Comprehensive Review

Overview
Journal Pain
Specialties Neurology
Psychiatry
Date 2016 Dec 20
PMID 27992392
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Central poststroke pain (CPSP) is a severe type of neuropathic pain that can develop after stroke and is difficult to treat. Research into its underlying mechanisms and treatment options could benefit from a valid CPSP animal model. Nine different CPSP animal models have been published, but there are relatively few reports on successful reproductions of these models and so far only little advances in the understanding or the management of CPSP have been made relying on these models. In general, the construct validity (similarity in underlying mechanisms) of these CPSP animal models is relatively high, although this cannot be evaluated into depth because of lack of understanding the mechanisms through which thalamic stroke can lead to CPSP. The face validity (symptom similarity) is relatively low, mainly because pain in these models is tested almost exclusively through evoked mechanical/thermal hypersensitivity assessed by reflexive measures and given the conflicting results with similar tests in patients with CPSP. The predictive validity (similarity in treatment efficacy) has not been evaluated in most models and incorporates difficulties that are specific to CPSP. We compare the different models regarding these types of validity and discuss the robustness, reproducibility, and problems regarding the design and reporting of the articles establishing these models. We conclude with various proposals on how to improve the validity and reproducibility of CPSP animal models. Until further improvements are achieved, prudence is called for in interpreting results obtained through these models.

Citing Articles

Spinal MCP-1 Contributes to Central Post-stroke Pain by Inducing Central Sensitization in Rats.

Yang F, Jing J, Fu S, Su X, Zhong Y, Chen D Mol Neurobiol. 2023; 60(4):2086-2098.

PMID: 36602702 DOI: 10.1007/s12035-022-03184-9.


Secondary damage and neuroinflammation in the spinal dorsal horn mediate post-thalamic hemorrhagic stroke pain hypersensitivity: SDF1-CXCR4 signaling mediation.

Liang T, Chen X, Yang Y, Yang F, Yu Y, Yang F Front Mol Neurosci. 2022; 15:911476.

PMID: 36034499 PMC: 9416701. DOI: 10.3389/fnmol.2022.911476.


Dissecting central post-stroke pain: a controlled symptom-psychophysical characterization.

Barbosa L, Aparecida da Silva V, Rodrigues A, Mendes Fernandes D, Oliveira R, Galhardoni R Brain Commun. 2022; 4(3):fcac090.

PMID: 35528229 PMC: 9070496. DOI: 10.1093/braincomms/fcac090.


Tricyclic antidepressants and selective serotonin reuptake inhibitors but not anticonvulsants ameliorate pain, anxiety, and depression symptoms in an animal model of central post-stroke pain.

Shyu B, He A, Yu Y, Huang A Mol Pain. 2021; 17:17448069211063351.

PMID: 34903115 PMC: 8679055. DOI: 10.1177/17448069211063351.


Lysophosphatidic acid LPA and LPA receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice.

Ueda H, Neyama H, Sasaki K, Miyama C, Iwamoto R Neurobiol Pain. 2019; 5:100020.

PMID: 31194070 PMC: 6550111. DOI: 10.1016/j.ynpai.2018.07.001.